Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma model

British Journal of Cancer (2012) - Comments
doi: 10.1038/bjc.2012.209 pubmed: 22588555 issn: 1532-1827

Y Kususda, H Miyake, M E Gleave, M Fujisawa